Clinical trial
BRAVO: Biomarker Risk Assessment in Vulnerable Outpatients
NCT02276781 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- BRAVO: Biomarker Risk Assessment in Vulnerable Outpatients
- Lead sponsor
- Northwestern University
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2009
- Completion date
- January 31, 2013
- Enrollment
- 595 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.